Literature DB >> 21653313

Methicillin-resistant Staphylococcus aureus guidelines: a myriad of open questions.

Jose Cadena, Marcos I Restrepo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21653313      PMCID： PMC3110283          DOI： 10.1093/cid/cir278

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

3.  Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes.

Authors:  David H Priest; James E Peacock
Journal:  South Med J       Date:  2005-09       Impact factor: 0.954

4.  Bacteremic Staphylococcus aureus spondylitis.

Authors:  A G Jensen; F Espersen; P Skinhøj; N Frimodt-Møller
Journal:  Arch Intern Med       Date:  1998-03-09

5.  Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Authors:  E Rubinstein; S Cammarata; T Oliphant; R Wunderink
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

6.  Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia.

Authors:  James Price; Gillian Baker; Ian Heath; Karen Walker-Bone; Marc Cubbon; Sally Curtis; Mark C Enright; Jodi Lindsay; John Paul; Martin Llewelyn
Journal:  Int J Microbiol       Date:  2010-03-16

7.  Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.

Authors:  Richard G Wunderink; Meryl H Mendelson; Michael S Somero; Timothy C Fabian; Addison K May; Helen Bhattacharyya; Kenneth V Leeper; Joseph S Solomkin
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

8.  A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.

Authors:  Feng-Yee Chang; Brent B MacDonald; James E Peacock; Daniel M Musher; Patricia Triplett; Joseph M Mylotte; Alice O'Donnell; Marilyn M Wagener; Victor L Yu
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

9.  Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.

Authors:  Ethan Rubinstein; Tahaniyat Lalani; G Ralph Corey; Zeina A Kanafani; Esteban C Nannini; Marcelo G Rocha; Galia Rahav; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Patrick C Lee; Arnold L Lentnek; Carlos M Luna; Jean-Yves Fagon; Antoni Torres; Michael M Kitt; Fredric C Genter; Steven L Barriere; H David Friedland; Martin E Stryjewski
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079
  9 in total
  1 in total

1.  Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Authors:  Guy Thwaites; Cressida Auckland; Gavin Barlow; Richard Cunningham; Gerry Davies; Jonathan Edgeworth; Julia Greig; Susan Hopkins; Dakshika Jeyaratnam; Neil Jenkins; Martin Llewelyn; Sarah Meisner; Emmanuel Nsutebu; Tim Planche; Robert C Read; Matthew Scarborough; Marta Soares; Robert Tilley; M Estée Török; John Williams; Peter Wilson; Sarah Wyllie; A Sarah Walker
Journal:  Trials       Date:  2012-12-18       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.